Acute rheumatic fever/rheumatic heart disease (ARF/RHD) register: example of priority based guidelines*
*Adapted from the Northern Territory Rheumatic Heart Disease Register 2003, with permission. |
Priority 1: severe disease |
Established RHD with any of: |
• A valvar lesion that is severe |
• A moderate to severe valvar lesion where left ventricular (LV) function is impaired or LV size is increased |
• A moderate to severe valvar lesion where there is shortness of breath, tiredness, oedema, angina, or syncope |
• History of bioprosthetic valve replacement (porcine or homograft), valve repair, valvotomy or metallic prosthetic valve replacement (until stabilised) |
Management: |
• Management by a cardiologist and consideration for surgery |
• Patients should be reviewed every 6 months by a specialist physician or paediatrician |
Priority 2: moderate disease |
Established RHD with any of: |
• A valvar lesion that is moderate, providing there are no symptoms and left ventricular function is normal |
• Mechanical prosthetic valves once stable following surgery |
• A child or adolescent with a history of chorea until 18 years old, even if there is no valve damage (>50% will subsequently develop valve disease) |
Management: |
• Managed by primary care doctor with review by specialist physician/paediatrician every year (or earlier if clinical deterioration) or within 3 months of hospital discharge following any episode of confirmed or suspected ARF |
• Echocardiogram recommended every year (children) or 2 years (adults) to assess valve lesion severity and LV function |
Priority 3: mild disease |
RHD or ARF: |
• A valvar lesion that is trivial to mild |
• History of ARF with no evidence of RHD |
Management: |
• Managed by primary care doctor unless clinical deterioration. Children and adolescent up to 18 years reviewed every year by a specialist physician or paediatrician |
• Echocardiogram every 2 years (children) or 5 years (adults, no recent ARF). |
• Any new diagnosis of ARF always requires specialist physician/paediatrician follow up within 3 months of hospital discharge to assess progress |
• Specialist physician review before ceasing secondary prophylaxis |